Julia Kern, MBA

Director Strategic Partnerships


SOMAREALITY creates eye-tracking based digital biomarkers which they deploy across various use cases in healthcare. In her current role, Julia informed SOMA’s first analytics product, cognitive load, from a market perspective and tied partnerships with both national as well as international research institutions and clients such as Stanford University, Medical University of Vienna, Children’s Hospital LA, NHS, Vamed Group and many more. At WTC in Munich, Julia shares her view on the potential of continuous neuropsychological monitoring as a logical, yet highly innovative succession of non-eye-tracking based technologies in healthcare.